Affordable Access

Publisher Website

SHANK3 deficiency leads to myelin defects in the central and peripheral nervous system

Authors
  • Malara, Mariagiovanna
  • Lutz, Anne-Kathrin
  • Incearap, Berra
  • Bauer, Helen Friedericke
  • Cursano, Silvia
  • Volbracht, Katrin
  • Lerner, Joanna Janina
  • Pandey, Rakshita
  • Delling, Jan Philipp
  • Ioannidis, Valentin
  • Arévalo, Andrea Pérez
  • von Bernhardi, Jaime Eugenin
  • Schön, Michael
  • Bockmann, Jürgen
  • Dimou, Leda
  • Boeckers, Tobias M.
Type
Published Article
Journal
Cellular and Molecular Life Sciences
Publisher
Springer-Verlag
Publication Date
Jun 20, 2022
Volume
79
Issue
7
Identifiers
DOI: 10.1007/s00018-022-04400-4
PMID: 35726031
PMCID: PMC9209365
Source
PubMed Central
Keywords
Disciplines
  • Original Article
License
Unknown

Abstract

Mutations or deletions of the SHANK3 gene are causative for Phelan–McDermid syndrome (PMDS), a syndromic form of autism spectrum disorders (ASDs). We analyzed Shank3Δ11(−/−) mice and organoids from PMDS individuals to study effects on myelin. SHANK3 was found to be expressed in oligodendrocytes and Schwann cells, and MRI analysis of Shank3Δ11(−/−) mice revealed a reduced volume of the corpus callosum as seen in PMDS patients. Myelin proteins including myelin basic protein showed significant temporal and regional differences with lower levels in the CNS but increased amounts in the PNS of Shank3Δ11(−/−) animals. Node, as well as paranode, lengths were increased and ultrastructural analysis revealed region-specific alterations of the myelin sheaths. In PMDS hiPSC-derived cerebral organoids we observed an altered number and delayed maturation of myelinating cells. These findings provide evidence that, in addition to a synaptic deregulation, impairment of myelin might profoundly contribute to the clinical manifestation of SHANK3 deficiency. Supplementary Information The online version contains supplementary material available at 10.1007/s00018-022-04400-4.

Report this publication

Statistics

Seen <100 times